These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5155338)

  • 21. [Variations in the level of immunosuppressive acidic protein in patients with gynecologic tumors and pregnant women].
    Sawada M; Okudaira Y; Matsui Y; Miyoshi Y; Takayama K; Shimizu Y; Miura S
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1823-30. PubMed ID: 6882005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical significance of tissue polypeptide antigen (TPA) and carbohydrate antigen 12-5 (CA 12-5) in the sera from patients with various gynecologic tumors].
    Tohya T; Inoue S; Tanaka N; Fujisaki S; Maeyama M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2872-5. PubMed ID: 3910744
    [No Abstract]   [Full Text] [Related]  

  • 23. [Dynamics of the level of properdin in the blood in rabbits during the process of formation of antitubercular immunity].
    Terterian EA
    Probl Tuberk; 1967; 45(3):73-6. PubMed ID: 5611175
    [No Abstract]   [Full Text] [Related]  

  • 24. [A study on clinical significance of oncofetal antigen-1 in gynecologic tumors].
    Takahashi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Dec; 36(12):2613-8. PubMed ID: 6520482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Carcino-embryogenic antigen (CEA) in patients with genital tumors (author's transl)].
    Anger H; Gleissenberger U
    Geburtshilfe Frauenheilkd; 1977 Jul; 37(7):604-8. PubMed ID: 885332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immuno-serologic examinations in pregnancy and genital neoplasms in women].
    Kadach D
    Zentralbl Gynakol; 1970 Nov; 92(48):1577-80. PubMed ID: 4099855
    [No Abstract]   [Full Text] [Related]  

  • 27. [Evaluation of serum ferritin in female genital neoplasms].
    Dong MY
    Zhonghua Fu Chan Ke Za Zhi; 1991 Jan; 26(1):21-3, 61. PubMed ID: 1848498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prospects of the use of neoplasm antigens as markers of gynecologic diseases].
    Adamian LV; Fanchenko ND; Andreeva EN; Novikov EA; Alekseeva ML
    Sov Med; 1990; (6):26-9. PubMed ID: 2204116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Microquantitative estimation of C-reactive protein (CRP) in sera from patients with tumors of female genital organs (author's transl)].
    Takizawa K; Kawana T; Shiromizu K; Sakamoto S
    Nihon Gan Chiryo Gakkai Shi; 1978 Dec; 13(6):712-20. PubMed ID: 744888
    [No Abstract]   [Full Text] [Related]  

  • 30. [Plasmafibronectin in case of tumors of the female genital system].
    Tatra G; Nasr F
    Strahlentherapie; 1983 Oct; 159(10):606-9. PubMed ID: 6417840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Natural immunity and malignant uterine neoplasms].
    DE CECCO L
    Quad Clin Ostet Ginecol; 1961 Oct; 16():726-40. PubMed ID: 13884167
    [No Abstract]   [Full Text] [Related]  

  • 32. [Patterns of alkaline phosphatase in leukocytes in gynecologic neoplasms].
    Krawczyk B; Pertyński T; Torbus B; Kuchowicz W; Dramiński M
    Wiad Lek; 1968 Sep; 21(15):1301-6. PubMed ID: 5697939
    [No Abstract]   [Full Text] [Related]  

  • 33. CA125 production by gynecologic tumors in vitro and its modulation induced by dibutyl cyclic adenosine monophosphate.
    Ishiwata I; Ishiwata C; Nozawa S; Ishikawa H
    Asia Oceania J Obstet Gynaecol; 1986 Jun; 12(2):285-90. PubMed ID: 2429643
    [No Abstract]   [Full Text] [Related]  

  • 34. [Nonspecific cell-mediated immunity of gynecologic cancer patients and related effects of chemotherapy and immunotherapy].
    Takada M
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1480-5. PubMed ID: 6409005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Transient form of serum albumin in gynecologic cancer].
    Rybalka AN; Bagdasar'ian SN; Garina TN; Karpilenko TM; Kasymova GA
    Biull Eksp Biol Med; 1984 Jan; 97(1):76-9. PubMed ID: 6692030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The properdin titer in women with labor pathology or gynecological disease and the role of this titer in the prognosis].
    Malkov JJ
    Zentralbl Gynakol; 1975; 97(17):1047-56. PubMed ID: 1189778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The immunologic and hormonal activity of gonadotropins in tumors of the female genital organs].
    Golubev VN
    Vopr Onkol; 1972; 18(2):42-6. PubMed ID: 5012915
    [No Abstract]   [Full Text] [Related]  

  • 38. [A study on tumor marker of tissue-polypeptide-antigen (TPA) in gynecologic malignancies].
    Nakajima H; Hirata T; Norisugi T; Furuno K; Ikehata N; Utsunomiya A; Kobayashi K; Negishi Y; Akiya K
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Oct; 36(10):1877-83. PubMed ID: 6094688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Radioimmunological determination of cancerocerebral antigen in the blood serum of patients with ovarian tumors].
    Griaznova IM; Borisenko SA; Sokolov AV; Prokopenko PG; Makarov OV
    Akush Ginekol (Mosk); 1984 Apr; (4):27-9. PubMed ID: 6204548
    [No Abstract]   [Full Text] [Related]  

  • 40. [Circulating T cells in patients with breast or genital cancers in the pre-therapeutic phase].
    Strache RR; Büttner HH; Kunze M; Röpcke G
    Zentralbl Gynakol; 1989; 111(12):816-23. PubMed ID: 2788342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.